ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,762Medicare Part D Prescriptions Filled, Including Refills

Rank: 227 out of 783

$434K Total Retail Price of All Prescriptions

Rank: 324 out of 783

581 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 581 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 581 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 7,582 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
OMEPRAZOLE 514 436 1 6
SIMVASTATIN 397 333 2 3
FUROSEMIDE 322 296 3 7
POTASSIUM CHLORIDE 321 283 4 16
LISINOPRIL 256 233 5 4
LEVOTHYROXINE SODIUM 240 219 6 1
METFORMIN HCL 231 192 7 8
HYDROCODONE-ACETAMINOPHEN 211 162 S3 8 2
ATENOLOL 164 152 9 17
ALENDRONATE SODIUM 147 147 10 25
WARFARIN SODIUM 145 133 11 10
NAMENDA 130 130 12 32
GLIMEPIRIDE 125 103 13 34
CITALOPRAM HBR 122 85 14 19
FENOFIBRATE 122 114 14 66
LOSARTAN POTASSIUM 119 107 16 18
METOPROLOL SUCCINATE 118 110 17 13
AMLODIPINE BESYLATE 114 97 18 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 87 19 33
LOVASTATIN 101 86 20 58
TRAMADOL HCL 101 91 20 20
SERTRALINE HCL 101 75 20 22
METOPROLOL TARTRATE 99 87 23 9
ATORVASTATIN CALCIUM 96 91 24 11
MELOXICAM 91 69 25 37
PREDNISONE 89 66 26 36
PRAVASTATIN SODIUM 88 77 27 14
TAMSULOSIN HCL 86 71 28 26
RANITIDINE HCL 81 80 29 44
HYDROCHLOROTHIAZIDE 78 78 30 12
NEXIUM 75 58 31 28
LANTUS 73 61 32 38
CRESTOR 68 58 33 27
LANTUS SOLOSTAR 60 56 34 91
ALLOPURINOL 59 52 35 31
DILTIAZEM ER 56 51 36 153
GABAPENTIN 55 38 37 15
POLYETHYLENE GLYCOL 3350 52 52 38 43
CELEBREX 52 50 38 93
BUSPIRONE HCL 52 45 38 124
PROAIR HFA 50 47 41 56
ROPINIROLE HCL 50 39 41 74
VENLAFAXINE HCL ER 50 50 41 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.